Rashtriya Newsflash

Press Release

Patrick Beason Unleashes Cryptid Terror in West Texas Shadow Walkers The Cryptid Invasion

Monsters Descend on the Lone Star State in This Thrilling Sci-Fi Horror Adventure What happens when the myths we fear become the monsters we must fight? In West Texas Shadow

Read Full Article

Prostate Cancer Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight

Prostate Cancer Competitive Landscape Prostate cancer companies are Curium, Merck, Telix Pharmaceuticals, Exelixis, AstraZeneca, AB Science, Lantheus, Pfizer, Jiangsu Hengrui Pharmaceuticals, Modra Pharmaceuticals, Bristol-Myers Squibb, MacroGenics, Syntrix Pharmaceuticals, Zenith Epigenetics,

Read Full Article

Schneider Electric Launches Veteran Hiring Initiative to Build Mission-Ready Workforce for Critical Facilities

Schneider Electric, a global energy technology leader, today announced a new initiative to recruit and train U.S. military veterans for careers in its Services business. The effort will create pathways

Read Full Article

Neuroblastoma Market Forecast (2025-2034) – Competitive Landscape, Clinical Trials, Market Size, Medication, Prevalence, Companies by DelveInsight

Neuroblastoma Market Neuroblastoma companies in the treatment market include United Therapeutics, EUSA Pharma, Y-mAbs Therapeutics, Clarity Pharmaceuticals, and many others. Neuroblastoma Market is expected to grow exponentially driven by Rising

Read Full Article

Multiple Sclerosis Market Forecast 2034: Competitive Landscape, FDA Approvals, Therapies, Emerging Drugs Highlighting Zenas Biopharma’s Obexelimab Phase 2 Success and Market Insights

Multiple Sclerosis Market Key multiple sclerosis companies such as Sanofi, Immunic, InnoCare Pharma, Tiziana Life Sciences, Biogen, J-Pharma, Bristol-Myers Squibb,

Read Full Article

Food Allergy Pipeline Insights Report 2025: Clinical Trial Progress, Breakthrough Drugs, and Companies Shaping the Future of Treatment | DelveInsight

DelveInsight’s “Food Allergy Pipeline Insight 2025” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Food

Read Full Article

Chemotherapy Induced Peripheral Neuropathy Pipeline Analysis Report 2025: Promising Clinical Candidates and Pharma Companies Revolutionizing Drug Development | DelveInsight

DelveInsight’s “Chemotherapy Induced Peripheral Neuropathy Pipeline Insight 2025” report provides comprehensive insights about 4+ companies and 5+ pipeline drugs in

Read Full Article

Myocardial Infarction Pipeline Drugs Insights Report 2025: Emerging Drugs, Ongoing Clinical Trials, and Leading Companies Transforming the Treatment Landscape | DelveInsight

DelveInsight’s, “Myocardial Infarction Pipeline Insight 2025” report provides comprehensive insights about 30+ companies and 40+ pipeline drugs in Myocardial Infarction

Read Full Article

Epilepsy Pipeline Drugs Insights Report 2025: Emerging Drugs, Ongoing Clinical Trials, and Leading Companies Transforming the Treatment Landscape | DelveInsight

DelveInsight’s “Epilepsy Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 90+ pipeline drugs in the Epilepsy pipeline

Read Full Article

Chronic Hepatitis B market in the 7MM was valued ~USD 1,603 million in 2025 over the forecast period (2025-34)

Chronic Hepatitis B market The Chronic Hepatitis B (CHB) market across the seven major markets (7MM), the United States, EU4

Read Full Article